Pioneering research.
Life-changing tests.

The Cunningham Panel is an aid to a physician’s diagnosis of an autoimmune-based neuropsychiatric disorder

Revolutionizing the way we look at mental disorders

Leaders in autoimmunity testing for neuropsychiatric illnesses

Turn to the Cunningham Panel™ for answers.

The Cunningham Panel™ is the only test of its kind in the world that helps identify whether an autoimmune dysfunction may be causing a person’s neuropsychiatric symptoms.
The panel measures levels of autoantibodies attacking certain proteins in the brain, including those that stimulate brain cells to increase production of excess neurotransmitters, triggering inflammation and abnormal behaviors. High levels of these autoantibodies indicate an individual may have an infection-induced autoimmune disorder.
The Cunningham Panel™ measures antibodies attacking the brain causing inflammation and abnormal behaviors

Mental illness, behavioral disorder, or an autoimmune problem?

In some individuals, common infections, like strep, influenza, mycoplasma pneumonia and sinusitis, can trigger an autoimmune dysfunction causing inflammation in the brain and a variety of neurologic and psychiatric symptoms, such as OCD, tics, ADHD, depression and behaviors associated with autism spectrum disorder.
“We can’t say how many kids with psychiatric symptoms have an underlying immune or inflammatory component to their disorder, but given the burgeoning research indicating that inflammation drives mood disorders and other psychiatric problems, it’s likely to be a large subset of children and even adults diagnosed with psychiatric illnesses.”
(Kiki Chang, MD, professor of psychiatry and behavioral sciences, Stanford University Medical School)

Science That Impacts Lives.

There is a growing body of scientific evidence documenting the connection between infection, inflammation, immune dysfunction and the development of neurologic and psychiatric illnesses. Following is a list of peer-reviewed journal articles by world-renowned researchers and clinicians investigating infection-induced autoimmune neurologic disorders.

Physicians worldwide are using the Cunningham Panel™ to help guide diagnosis and target treatments.

  • Moleculera Labs: Our Mission
    Dr. Craig Shimasaki, president and CEO of Moleculera Labs, discusses the company’s mission to develop and offer advanced testing services that will help clinicians identify autoimmune-induced neuropsychiatric conditions.
  • Autoimmunity testing with the Cunningham Panel™
    Dr. Madeleine Cunningham explains how the Cunningham Panel™ can assist in determining whether an autoimmune process may be causing a person’s neurologic and/or psychiatric symptoms.
  • testimonial Wendy
    “My son began having symptoms of ADHD and autism. He had severe social anxiety and fits of rage. The doctors didn’t have an answer. He had a history of strep infections and eventually a psychiatrist suspected he had PANDAS. The Cunningham Panel™ test results confirmed the diagnosis and helped the doctor develop a treatment plan. The test gave us piece of mind that we finally had the right answer.”
    The Cunningham Panel™ can help identify the level of autoimmune antibodies associated with Neuropsychiatric Disorders
  • testimonial Martha
    “I am so thankful to have had the Cunningham Panel™ to confirm my daughter’s PANDAS diagnosis. Your nurse hit the nail on the head when she pointed out that one of her high markers can be associated with anger. That is the first thing we notice when she begins to flare, and no one else ever made this connection. We are so appreciative to have quantifiable results because we second-guessed ourselves so many times, and now we know it's not just our imagination, bad parenting or some kind of hidden psychiatric illness. Thank you so much for giving us hope!”
    The Cunningham Panel™ can help identify the level of autoimmune antibodies associated with Neuropsychiatric Disorders
  • testimonial Lori
    “We had the Cunningham Panel™ test done on my daughter. She had OCD, separation anxiety and tics but also a lot of physical discomfort from joint pain and muscle aches. She was in treatment but never got completely well. The test results confirmed she had an autoimmune problem. I am so grateful we had a test that could help us figure out the diagnosis and determine the best treatment plan.”
    The Cunningham Panel™ can help identify the level of autoimmune antibodies associated with Neuropsychiatric Disorders

Remarkable results happen here.

Infection-triggered autoimmune disorders, such as PANS/PANDAS, which cause neuropsychiatric symptoms can be difficult to recognize. The following videos provide insight into the complexity of these disorders and demonstrate how the Cunningham Panel™ can assist physicians.


  • Please tell us about yourself so we can send you the appropriate updates on Neuropsychiatric Disorders testing and research.